The 40-Gene Expression Profile (40-GEP) Test Allows for an Improved Prognostication of the Likelihood of Metastasis in Patients with T1 Cutaneous Squamous Cell Carcinoma (cSCC) with High-Risk Factors
Authors: Ally‐Khan Somani, MD, PhD; Javier Cañueto MD, PhD; Vincent Smith, DNP, ANP-C; Andrew Berg, NP-C; Alison L. Fitzgerald, PhD; Jennifer J. Siegel, PhD; Anesh Prasai, PhD; Sherrif F. Ibrahim, MD, PhD; Sarah T. Arron, MD, PhD
< PREVIOUS POSTER NEXT POSTER >
